🇺🇸 Standard therapy in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Acute Respiratory Distress Syndrome — 1 report (10%)
2. Calcinosis — 1 report (10%)
3. Cerebral Vasoconstriction — 1 report (10%)
4. Complications Of Transplanted Pancreas — 1 report (10%)
5. Enterococcal Infection — 1 report (10%)
6. Fluid Overload — 1 report (10%)
7. Fungal Rash — 1 report (10%)
8. Myocardial Infarction — 1 report (10%)
9. Pancreas Transplant — 1 report (10%)
10. Pancreatic Necrosis — 1 report (10%)

Source database →

Frequently asked questions

Is Standard therapy approved in United States?

Standard therapy does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Standard therapy in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.